BBH vs. HELX
Compare and contrast key facts about VanEck Vectors Biotech ETF (BBH) and Franklin Genomic Advancements ETF (HELX).
BBH and HELX are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BBH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Biotech 25 Index. It was launched on Dec 20, 2011. HELX is an actively managed fund by Franklin Templeton. It was launched on Feb 25, 2020.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BBH or HELX.
Correlation
The correlation between BBH and HELX is 0.84, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
BBH vs. HELX - Performance Comparison
Key characteristics
BBH:
0.00
HELX:
-0.06
BBH:
0.12
HELX:
0.04
BBH:
1.01
HELX:
1.01
BBH:
0.00
HELX:
-0.02
BBH:
0.01
HELX:
-0.19
BBH:
5.03%
HELX:
5.70%
BBH:
16.56%
HELX:
18.20%
BBH:
-72.69%
HELX:
-56.33%
BBH:
-27.38%
HELX:
-49.73%
Returns By Period
The year-to-date returns for both stocks are quite close, with BBH having a -4.08% return and HELX slightly lower at -4.17%.
BBH
-4.08%
-1.13%
-5.76%
-1.55%
2.50%
3.89%
HELX
-4.17%
-0.14%
-8.17%
-2.69%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BBH vs. HELX - Expense Ratio Comparison
BBH has a 0.35% expense ratio, which is lower than HELX's 0.50% expense ratio.
Risk-Adjusted Performance
BBH vs. HELX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and Franklin Genomic Advancements ETF (HELX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BBH vs. HELX - Dividend Comparison
Neither BBH nor HELX has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.00% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% | 0.00% | 0.00% |
HELX Franklin Genomic Advancements ETF | 0.00% | 0.00% | 0.00% | 0.24% | 0.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
BBH vs. HELX - Drawdown Comparison
The maximum BBH drawdown since its inception was -72.69%, which is greater than HELX's maximum drawdown of -56.33%. Use the drawdown chart below to compare losses from any high point for BBH and HELX. For additional features, visit the drawdowns tool.
Volatility
BBH vs. HELX - Volatility Comparison
The current volatility for VanEck Vectors Biotech ETF (BBH) is 5.16%, while Franklin Genomic Advancements ETF (HELX) has a volatility of 6.43%. This indicates that BBH experiences smaller price fluctuations and is considered to be less risky than HELX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.